Dr. David G. Brown is a Pasadena, California based male rheumatologist who is specialized in Rheumatology. Active license number of Dr. David G. Brown for Rheumatology is G48947 in California. Dr. David G. Brown treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. David G. Brown speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Male
Practice Address:
675 S Arroyo Pkwy, Suite # 400, Pasadena, California, 91105-3263
Phone:
626-795-4116
Fax:
626-568-3127
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1689710055
NPI Enumeration Date:
30 Jan, 2007
NPI Last Update On:
08 Apr, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. David G. Brown are as mentioned below.
License Number
Specialization
State
Status
G48947
Rheumatologist
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
675 S Arroyo Pkwy, Suite # 400 Pasadena, California
Zip:
91105-3263
Phone Number:
626-795-4116
Fax Number:
626-568-3127
Patients can reach Dr. David G. Brown at 675 S Arroyo Pkwy, Suite # 400, Pasadena, California or can call to book an appointment on 626-795-4116. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.